Quantum International develops medical testing software for Apple iPad

NewsGuard 100/100 Score

Cutting-edge technology company Quantum International Corp. (OTCBB: QUAN) announced today that it has begun development on an innovative new accessory for the Apple (NASDAQ: AAPL) iPad that could potentially revolutionize mobile medical testing.

The MediCase is envisioned to be a unique, protective case for the iPad that will contain built-in essential medical testing capabilities, including meters for body temperature, blood pressure, pulse, blood oxygen levels, blood sugar levels and more. Quantum has begun developing the support software necessary to allow the results to be collected by anyone with an iPad and stored or transmitted to a physician.

The MediCase is the first product planned in a series of lifestyle enhancement products that will enable older consumers and specific industries to better utilize new technologies such as the iPad, from aging business professionals to underserved industries and beyond.

The global market for iPad accessories is growing at an astonishing rate due to the device's paradigm-shifting popularity. Currently, there are more than 117 million iPad owners worldwide, and the market for accessories is worth $2.3 billion and climbing.

Quantum is working hard to capitalize on that growth. Earlier this year, the company signed a joint venture agreement with A Plus Technologies to develop and market a new line of electronic lifestyle enhancement technologies, including iPad accessories.

Source:

Quantum International Corp.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
When mass spectrometry redefines the pharma industry